NEW YORK (GenomeWeb) – The nation's top lab industry group is mulling legal strategies as part of its overall push to thwart regulation of laboratory-developed tests (LDTs) by the US Food and Drug Administration.

The American Clinical Laboratory Association announced today that it has retained Solicitor General Paul Clement, a partner at Bancroft PLLC, and Laurence Tribe, constitutional law professor at Harvard University, for "representation on matters relating to the FDA's recently issued draft guidance to regulate LDTs as medical devices."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.